VIDEO

FindCenter AddIcon

The Push to Decriminalize ‘Magic Mushrooms’

By Mark Haden — 2019

Denver the first U.S. city to decriminalize psilocybin, the psychoactive ingredient in so-called magic mushrooms. See more...

05:38 min

43:07

Bob Jesse: “Entheogens, Awakening, and Spiritual Development” | Horizons 2009

Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.

FindCenter AddIcon
27:34

Ketamine Therapy: A Disruptive Treatment Paradigm

Ketamine is a controversial yet effective treatment in psychiatry, and it arrives at a much needed time as depression and suicide rates have reached crisis levels in the United States.

FindCenter AddIcon
15:53

MDMA, Psychotherapy, and the Future of PTSD Treatment | Brad Burge | TEDxSalem

Rethinking the role of psychedelic drugs and how they can help to improve the lives of our country’s military personnel and others suffering from PTSD.

FindCenter AddIcon
07:13

How MDMA Is Being Used to Treat PTSD | The Economist

MDMA, the active ingredient in the party drug ecstasy, is being touted as a game-changing treatment for post-traumatic stress disorder. It is being trialled in America-and for one army veteran the drug has been a life-saver. In America around 22 military veterans kill themselves every day.

FindCenter AddIcon
30:35

There Is No Such Thing as a “Bad Drug” | Psychedcast Ft. Mark Haden

Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.

FindCenter AddIcon
03:03

Breakthrough for Psychedelic Medicine

FindCenter AddIcon
07:41

Roland Griffiths: Psilocybin Research for Anxiety & Psychological Distress

FindCenter AddIcon
15:59

The Science of Psilocybin and Its Use to Relieve Suffering

Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.

FindCenter AddIcon
01:20:04

Paul Stamets at the Psilocybin Summit 2020 - Psilocybin Mushrooms & Their Emergent Medicines

Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.

FindCenter AddIcon
42:53

The Treasure Called the Psilocybes: Paul Stamets

In the second half of an extended talk at SAND 18, Paul Stamets, author, mycologist, medical researcher and entrepreneur, tells stories of the early years of research into psychoactive mushrooms, and describes a number of species and their characteristics, in particular psilocybes.

FindCenter AddIcon

EXPLORE TOPIC

Drug Policy